Solara Active Pharma Sciences informs about transcript of conference call

21 Feb 2024 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Solara Active Pharma Sciences has informed that it enclosed the transcript of the earnings conference call for the quarter ended December 31, 2023, conducted after the meeting of Board of Directors held on February 14, 2024. The above information is also available on the website of Company at https://solara.co.in/investorrelations/investor-update.

The above information is a part of company’s filings submitted to BSE.

Solara Active Pharma Share Price

556.45 0.00 (0.00%)
14-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1700.55
Dr. Reddys Lab 1186.45
Cipla 1434.60
Zydus Lifesciences 884.00
Lupin 2195.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×